Form D · Biotechnology

Nirva Medical, LLC

Vadnais Heights, MN · CIK 0001602486

Offering snapshot reported Apr 20, 2015 · SEC filing

Reported sold
$260K
Offering amount: $750K
Investors reported
9
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Mar 25, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$130K$260KMar 28, 2014: $30,000.00Mar 28, 2014Apr 20, 2015: $260,000.00Apr 20, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$30,000 → $260,000
  • Reported investors1 → 9

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 20, 2015Amendment$260,000$230,000vs Mar 28, 20149SEC filing
Mar 28, 2014Initial$30,000No comparison1SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-214467

Source: Form D, filed Apr 20, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Pramote Hochareon Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
799 Clearbook Lane
Vadnais Heights, MN, 55127